Bionic Sight LLC
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Bionic Sight LLC
RECRUITINGPhase 1 / Phase 2NCT07158775
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With...
This is a Phase 1/2 study, multi-center, dose-escalation interventional study of BS01 in subjects with GA secondary to dry AMD. Part 1 is an open label dose-escalation study; Part...
Sponsor: Bionic Sight LLCEnrolling: 401 location
Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
RECRUITINGPhase 1 / Phase 2NCT04278131
BS01 in Patients With Retinitis Pigmentosa
A Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP (AAV2-CAG-ChronosFP) in Patients with Retinitis Pigmentosa
Sponsor: Bionic Sight LLCEnrolling: 201 location
Retinitis Pigmentosa